header image

Take a look through our annual reports.

How to contact us for media/press enquiries.

Have a comment or question? Get in touch.

News

Chris Bombardier, First Hemophiliac to Climb the Seven Summits, Joins Octapharma USA at HFA Annual Symposium in Cleveland

04-26-2018

Mountain Climber Will Discuss Mount Everest Climb, Upcoming Documentary One-on-One With Visitors of Octapharma Booth

Octapharma USA Grant Supports National Conference for Type 3 von Willebrand Disease Patients

04-11-2018

‘Making the Connection’ will be held June 22 – 25 in Palm Beach Gardens, Florida

Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million

03-01-2018

Lachen, Switzerland, March 1st, 2018: Over the last six years, the Octapharma Group has accomplished a remarkable compound annual growth rate of 15% and reports another record-breaking result for 2017, with sales of €1.72 billion...

Octapharma Support Enables Bombardier to Climb Mount Vinson, Becoming First Hemophiliac to Ascend the Seven Summits

01-25-2018

Octapharma Partnership with Mountain Climber will Culminate with Release of Documentary Bombardier Blood Later This Year

Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

01-22-2018

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. The study...